The year ahead will see major initiatives take significant steps in shaping the future of clinical trials globally. From the anticipated public consultation on updated ICH Good Clinical Practice guidance to new World Health Organization (WHO) Guidance on Best Practices for Clinical Trials...
The Collaborative responded to a recent call for input from the White House Office for Science & Technology Policy on how the U.S. and the world can mount a better clinical trials response to future health emergencies. Our response makes five recommendations on priority actions…
The Collaborative welcomes the endorsement of our Guidance in the joint opinion by world cardiology leaders European Society of Cardiology, American Heart Association, World Heart Federation and American College of Cardiology about the need for better RCTs in this rapidly changing and increasingly global world...
The Collaborative was invited by Mahidol Oxford Tropical Medicine Research Unit to participate virtually on a panel about what makes a good randomized controlled trial at the Joint International Tropical Medicine Meeting in December 2022.
The Collaborative’s work is to promote better, more efficient randomized controlled trials for any type of intervention, in any setting, anywhere in the world. We were therefore delighted when The Global Health Network invited us to share our Guidance at their global conference in Cape…
Good guidelines are needed to facilitate the generation of reliable answers to important questions about the benefits and hazards of medical interventions, says Professor Sir Martin Landray.
The number of clinical trials conducted across the world is expected to rise in coming years on the back of continued demand for new innovative products and medical technologies. This could be a positive trend for global healthcare, but what tools do we have to…
An abundance of tools is widely available to researchers today that can empower clinical trials to be more adaptive, connected, efficient, flexible, resilient and transparent.